Altered GABAergic Signaling in Brain Disease at Various Stages of Life.
- Author:
Yoo Sung KIM
1
;
Bo Eun YOON
Author Information
- Publication Type:Review
- Keywords: GABA; brain disorder; lifespan; excitatory/inhibitory balance; neurodegenerative disease; neurodevelopmental disease
- MeSH: Brain Diseases*; Brain*; gamma-Aminobutyric Acid; Neurodegenerative Diseases; Neuroglia; Neurons; Social Problems
- From:Experimental Neurobiology 2017;26(3):122-131
- CountryRepublic of Korea
- Language:English
- Abstract: In the healthy brain, gamma-aminobutyric acid (GABA) is regulated by neurons and glia. This begs the question: what happens in the malfunctioning brain? There are many reasons why diseases occur, including genetic mutations, systemic problems, and environmental influences. There are also many ways in which GABA can become dysregulated, such as through alterations in its synthesis or release, and changes in systems that respond to it. Notably, dysregulation of GABA can have a large impact on the brain. To date, few reviews have examined brain diseases in which dysregulation of GABA is implicated as an underlying factor. Accordingly, the time is ripe for investigating alterations in GABAergic signaling that may play a role in changes in neuronal activity observed in the major brain disorders that occur during various stages of life. This review is meant to provide a better understanding of the role of GABA in brain health and contributor to social problems from a scientific perspective.
